國立高雄大學圖資館 |

Language: English

Back

New anti-cancer drug development and evaluation

Record Type:	Electronic resources : Monograph/item
Title/Author:	New anti-cancer drug development and evaluationedited by Yongchang Zhang, Nong Yang.
other author:	Zhang, Yongchang.
Published:	Singapore :Springer Nature Singapore :2024.
Description:	xxvii, 232 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Antineoplastic agents.
Online resource:	https://doi.org/10.1007/978-981-97-7274-2
ISBN:	9789819772742$q(electronic bk.)

New anti-cancer drug development and evaluation
New anti-cancer drug development and evaluation[electronic resource] /edited by Yongchang Zhang, Nong Yang. - Singapore :Springer Nature Singapore :2024. - xxvii, 232 p. :ill., digital ;24 cm.

Chapter 1. Transformations and Challenges in Cancer Treatment -- Chapter 2. Drug(gable) Targets Discovery -- Chapter 3. Preclinical and Translational Study Design -- Chapter 4. Clinical Trials -- Chapter 5. Small Molecule Compounds -- Chapter 6. Antibodies -- Chapter 7. Cell Guided Drugs -- Chapter 8. Gene Guided Drugs -- Chapter 9. Biosimilar -- Chapter 10. New Insights on Success and Failed Drugs -- Chapter 11. The Road from Laboratory to Patient.

This book aims to help researchers to understand the current status of new drug development in China and major events experienced in the development of new drugs. It also helps clinicians and basic research scientists to grasp the types, indications, and adverse reactions of common new drugs; clarifies key events experienced during the launch of new drugs; and discusses future perspectives of clinical medicine development. This book is also beneficial to clinicians by helping them to better become physician scientists.

ISBN: 9789819772742$q(electronic bk.)

Standard No.: 10.1007/978-981-97-7274-2doiSubjects--Topical Terms:

229375
Antineoplastic agents.

LC Class. No.: RC271.C5

Dewey Class. No.: 615.798

New anti-cancer drug development and evaluation
LDR:01953nmm a2200325 a 4500 001 673521
003 DE-He213
005 20241209115243.0
006 m d
007 cr nn 008maaau
008 250422s2024 si s 0 eng d
020 $a 9789819772742$q(electronic bk.)
020 $a 9789819772735$q(paper)
024 7 $a 10.1007/978-981-97-7274-2 $2 doi
035 $a 978-981-97-7274-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.C5
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.798 $2 23
090 $a RC271.C5 $b N532 2024
245 0 0 $a New anti-cancer drug development and evaluation $h [electronic resource] / $c edited by Yongchang Zhang, Nong Yang.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xxvii, 232 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Transformations and Challenges in Cancer Treatment -- Chapter 2. Drug(gable) Targets Discovery -- Chapter 3. Preclinical and Translational Study Design -- Chapter 4. Clinical Trials -- Chapter 5. Small Molecule Compounds -- Chapter 6. Antibodies -- Chapter 7. Cell Guided Drugs -- Chapter 8. Gene Guided Drugs -- Chapter 9. Biosimilar -- Chapter 10. New Insights on Success and Failed Drugs -- Chapter 11. The Road from Laboratory to Patient.
520 $a This book aims to help researchers to understand the current status of new drug development in China and major events experienced in the development of new drugs. It also helps clinicians and basic research scientists to grasp the types, indications, and adverse reactions of common new drugs; clarifies key events experienced during the launch of new drugs; and discusses future perspectives of clinical medicine development. This book is also beneficial to clinicians by helping them to better become physician scientists.
650 0 $a Antineoplastic agents. $3 229375
650 0 $a Cancer $x Chemotherapy. $3 194707
650 0 $a Drug development. $3 190608
650 1 4 $a Pharmacology. $3 218135
650 2 4 $a Preclinical Research. $3 923734
650 2 4 $a Clinical Research. $3 911843
700 1 $a Zhang, Yongchang. $3 987053
700 1 $a Yang, Nong. $3 987054
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-7274-2
950 $a Medicine (SpringerNature-11650)